Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant Human PAK2 Protein, N-His

Catalog #:   YHG43201 Specific References (50) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: Q13177
Protein length: Glu177-Ala419
Overview

Catalog No.

YHG43201

Expression system

E. coli

Species

Homo sapiens (Human)

Protein length

Glu177-Ala419

Predicted molecular weight

29.16 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

Q13177

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

S6/H4 kinase, p21-activated kinase 2, p58, PAK-2, PAK2, C-t-PAK2, PAK65, p34, Gamma-PAK, Serine/threonine-protein kinase PAK 2, p27

Data Image
  • SDS-PAGE
    SDS PAGE for recombinant Human PAK2 protein
References

Using proteomics and single-cell sequencing to analyze the pathogenesis of recurrent implantation failure associated with uterine natural killer cells., PMID:40514455

Inhibition of virally induced TFEB proteasomal degradation as a host-centric therapeutic approach for coronaviral infection., PMID:40465712

An integrated proteomics approach identifies phosphorylation sites on viral and host proteins that regulate West Nile virus infection., PMID:40381193

Chinese Family With Knobloch Syndrome Associated With a Novel PAK2 Variant Leading to Reduced Phosphorylation Levels., PMID:40247748

4D label-free quantitative proteomic and phosphoproteomic profiling of the kidney in rat models of antimyeloperoxidase-associated vasculitis., PMID:40201969

Acetylation of METTL3: A negative regulator of m6A deposition on chromatin-associated regulatory RNAs., PMID:40185074

Mechanical forces trigger invasive behavior in synovial fibroblasts through N-cadherin/ADAM15 -dependent modulation of LncRNA H19., PMID:40118917

Spatial control of m6A deposition on enhancer and promoter RNAs through co-acetylation of METTL3 and H3K27 on chromatin., PMID:40101711

P21-Activated Kinase 2 as a Novel Target for Ventricular Tachyarrhythmias Associated with Cardiac Adrenergic Stress and Hypertrophy., PMID:40068092

TC10 on endosomes regulates the local balance between microtubule stability and dynamics through the PAK2-JNK pathway and promotes axon outgrowth., PMID:40008675

The Important Role of p21-Activated Kinases in Pancreatic Exocrine Function., PMID:40001881

aFGF gene-modified adipose-derived mesenchymal stem cells promote healing of full-thickness skin defects in diabetic rats., PMID:40001190

Antenatal phenotype associated with PAK2 pathogenic variants: bilateral pleural effusion as a warning sign., PMID:39994693

The proteomic landscape of diffuse midline glioma highlights the therapeutic potential of non-histone protein methyltransferases., PMID:39954016

HIV immune evasin Nef enhances allogeneic CAR T cell potency., PMID:39884316

Phenotypic Expansion of Knobloch Syndrome Type 2 in an Individual With a De Novo PAK2 Variant., PMID:39876536

Dynamics of resistance to immunotherapy and TKI in patients with advanced renal cell carcinoma., PMID:39799795

Targeting P21-Activated Kinase 2 as a Novel Therapeutic Approach to Mitigate Endoplasmic Reticulum Stress in Heart Failure With Preserved Ejection Fraction., PMID:39791428

Regulation of Cancer Metastasis by PAK2., PMID:39769207

Regulation of Vascular Injury and Repair by P21-Activated Kinase 1 and P21-Activated Kinase 2: Therapeutic Potential and Challenges., PMID:39766303

PAK2 as a therapeutic target in cancer: Mechanisms, challenges, and future perspectives., PMID:39694422

Imatinib is effective in some PDGFRA/B-negative hypereosinophilic syndromes: A step closer to unveiling underlying mechanisms., PMID:39468717

Phase II trial of imatinib mesylate in patients with PDGFRA/B-negative hypereosinophilic syndrome., PMID:39389908

The up-regulation of PAK2 indicates unfavorable prognosis in patients with serous epithelial ovarian cancer and contributes to paclitaxel resistance in ovarian cancer cells., PMID:39350056

Physical exercise-induced circAnks1b upregulation promotes protective endoplasmic reticulum stress and suppresses apoptosis via miR-130b-5p/Pak2 signaling in an ischemic stroke model., PMID:39328024

Integrated ceRNAs regulating relationship and bioinformatics analysis to study the molecular mechanisms of the inhibition of puerarin on bladder cancer cell., PMID:39133645

Synergistic effect of PAK and Hippo pathway inhibitor combination in NF2-deficient Schwannoma., PMID:39083549

O-demethyl galantamine alters protein expression in cerebellum of 5xFAD mice., PMID:39050707

Study of the genetic association between selected 3q29 region genes and schizophrenia and autism spectrum disorder in the Japanese population., PMID:38962417

New kinase-deficient PAK2 variants associated with Knobloch syndrome type 2., PMID:38894571

PAK2 promotes proliferation, migration, and invasion of lung squamous cell carcinoma through LIMK1/cofilin signaling pathway., PMID:38828848

Genetic mutation and immune infiltration in embryonal tumor with multilayered rosettes., PMID:38802706

Porocarcinomas with PAK1/2/3 fusions: a series of 12 cases., PMID:38785043

A de novo variant in PAK2 detected in an individual with Knobloch type 2 syndrome., PMID:38712026

Kinase activities in pancreatic ductal adenocarcinoma with prognostic and therapeutic avenues., PMID:38650175

ACSL4 promotes malignant progression of Hepatocellular carcinoma by targeting PAK2 transcription., PMID:38615921

The protein composition of exosomes released by prostate cancer cells is distinctly regulated by androgen receptor-antagonists and -agonist to stimulate growth of target cells., PMID:38589887

Engineered hsa-miR-455-3p-Abundant Extracellular Vesicles Derived from 3D-Cultured Adipose Mesenchymal Stem Cells for Tissue-Engineering Hyaline Cartilage Regeneration., PMID:38508211

Identification of microRNA-mRNA Regulatory Networks with Therapeutic Values in Alzheimer's Disease by Bioinformatics Analysis., PMID:38427479

Icariin Attenuates Human Renal Tubular Epithelial Cell Senescence by Targeting PAK2 via miR-23b-3p., PMID:38375837

Molecular mechanisms of pancreatic cancer liver metastasis: the role of PAK2., PMID:38343537

Anticancer mechanism of coumarin-based derivatives., PMID:38340509

Whole exome sequencing and polygenic assessment of a Swedish cohort with severe developmental language disorder., PMID:38300321

PAK inhibitor FRAX486 decreases the metastatic potential of triple-negative breast cancer cells by blocking autophagy., PMID:38110664

PAK2 is necessary for myelination in the peripheral nervous system., PMID:38079473

A novel pipeline for prioritizing cancer type-specific therapeutic vulnerabilities using DepMap identifies PAK2 as a target in head and neck squamous cell carcinomas., PMID:37997254

Case report: Blotchy skin in a puffy neonate: is there a new association?, PMID:37808560

Comprehensive Genomic Analysis of Puerarin in Inhibiting Bladder Urothelial Carcinoma Cell Proliferation and Migration., PMID:37694778

Gastrodin ameliorates cognitive dysfunction in diabetes by inhibiting PAK2 phosphorylation., PMID:37610708

Gene fusions in poroma, porocarcinoma and related adnexal skin tumours: An update., PMID:37609771

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human PAK2 Protein, N-His [YHG43201]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only